Miguel-Angel Luque-Fernandez

22PUBLICATIONS
29CO-AUTHORS
Psychosocial aspects of childbirth and perinatal mental healthEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 21, 2026
Glycated CD59, a Novel Biomarker for Gestational Diabetes.

|Mar 13, 2025
Guidelines and Best Practices for the Use of Targeted Maximum Likelihood and Machine Learning When Estimating Causal Effects of Exposures on Time-To-Event Outcomes.

Denis Talbot, Awa Diop, Miceline Mésidor

|Nov 14, 2023
Correction: Inequalities in treatment among patients with colon and rectal cancer: a multistate survival model using data from England National Cancer Registry 2012-2016.

Suping Ling, Miguel-Angel Luque Fernandez, Manuela Quaresma

|Sep 23, 2023
Inequalities in treatment among patients with colon and rectal cancer: a multistate survival model using data from England national cancer registry 2012-2016.

Suping Ling, Miguel-Angel Luque Fernandez, Manuela Quaresma

|Oct 27, 2022
Mediating Effects of Diagnostic Route on the Comorbidity Gap in Survival of Patients with Diffuse Large B-Cell or Follicular Lymphoma in England.

Matthew J Smith, Bernard Rachet, Miguel Angel Luque-Fernandez

|Jul 09, 2022
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland.

Delia Bogdanet, Michelle Toth Castillo, Helen Doheny

Pageof 4

Frequent Collaborators

4 joint publications

Matthew James Smith

4 joint publications

Aurélien Belot

3 joint publications

Bernard Rachet

3 joint publications

María-José Sánchez